Development, combination, formulation and encapsulation of bioactives from microalgae for skin care
Public support
Provider
Ministry of Education, Youth and Sports
Programme
Eurostars
Call for proposals
Eurostars 1 (SMSM20167D001)
Main participants
EcoFuel Laboratories s.r.o.
Contest type
VS - Public tender
Contract ID
MSMT-/2016-1
Alternative language
Project name in Czech
Vývoj, kombinace, formulace a enkapsulace bioaktivních látk z mikrořas pro péči o pleť
Annotation in Czech
Česko-Španělský projekt si klade za cíl biotechnologicky, pomocí mikrořas, produkovat bioaktivní látky - Omega -3 kyseliny dokosahexaenovou (DHA) a eikosapentaenovou (EPA), kyselinu arachidonovou (ARA) a karotenoid Astaxanthin. Tyto účinné látky následně stabilizovat a enkapsulovat a na základě jejich kombinace vyvinout kosmetické složky využitelné v oblasti prémiové nutra-kosmetiky a farma-kosmetiky do přípravků pro specifické kožní problémy (akné, lupénka, atopický ekzém, loupající se pokožka). Český projektový partner realizuje vývoj heterotrofní kultivace kmenů produkujících DHA, zvětšení měřítka procesu, extrakci a purifikaci DHA z buněčné biomasy, jakož i screening kmenů mikrořas s potenciálem heterotrofní produkce EPA. Španělští partneři projektu pak zajistí produkci ARA a Astaxanthinu ve fotobioreaktorech, jakož i vývoj směsného enkapsulovaného lipozomálního preparátu.
Scientific branches
R&D category
AP - Applied research
CEP classification - main branch
EI - Biotechnology and bionics
CEP - secondary branch
GM - Food industry
CEP - another secondary branch
CI - Industrial chemistry and chemical engineering
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
20401 - Chemical engineering (plants, products)<br>20402 - Chemical process engineering<br>20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>21101 - Food and beverages<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)
Project results evaluation
A prototype of the DHA-rich oil from microalgae was prepared by the procedure, which has been optimalized within the DIMASKIN project. The product was handed over to the foreign partners together with associated documentation. The effects of additional growth conditions were tested for their potential to further increase production of DHA by microalgae. First emulsions combining the oil, parfums and plant extracts were prepared to be used as ingredients in cosmetic products.
Solution timeline
Realization period - beginning
Sep 1, 2016
Realization period - end
Aug 31, 2019
Project status
U - Finished project
Latest support payment
Feb 1, 2019
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP20-MSM-7D-U/01:1
Data delivery date
Jun 9, 2020
Finance
Total approved costs
9,592 thou. CZK
Public financial support
4,796 thou. CZK
Other public sources
4,796 thou. CZK
Non public and foreign sources
0 thou. CZK